Pfizer Inc. (PFE) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Pfizer shareholders at a glance

The largest holder of Pfizer stock is BlackRock Advisors LLC, with 384.1 million shares (6.74% of the company), worth about $10.93 billion as of September 25, 2026. The 10 largest holders together own 31.2%.

In Q2 2026, 2,975 institutional holdings reports listed 4.05 billion shares worth $102.00 billion, up 7.7% in shares from Q1 2026.

Insiders reported 33 transactions in the last two years: 3 sales worth $199,486 and 5 purchases. The newest one on file is from August 12, 2026 (Bourla Albert, Chief Executive Officer).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through August 12, 2026.

PFE logo

Pfizer Inc.

PFEUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
2975
Options Value
$4.42B
Value (excl. Options)
$102.00B
Shares (excl. Options)
4.05B

Ownership by Type

Geographic Distribution

Largest Pfizer shareholders

HolderShares% of companyValue
BlackRock Advisors LLC384.1 million6.74%$10.9B
Vanguard Capital Management LLC372.1 million6.53%$10.6B
State Street Corporation307.1 million5.39%$8.7B
Geode Capital Management LLC135.3 million2.37%$3.9B
Ishares (DE) InvAG mit Teilgesellschaftsvermogen134.1 million2.35%$3.8B
Vanguard Portfolio Management LLC119.2 million2.09%$3.4B
Fisher Asset Management LLC109.1 million1.91%$3.1B
Eaton Vance Management96.3 million1.69%$2.7B
Norges Bank (13F)61.5 million1.08%$1.8B
Vanguard Fiduciary Trust Co.60.6 million1.06%$1.7B

As of September 25, 2026.

Pfizer institutional holdings by quarter

QuarterReportsSharesValue
Q2 20262,9754.05 billion$102.0B
Q1 20263,1133.76 billion$106.0B
Q4 20253,0843.75 billion$93.4B
Q3 20252,9983.66 billion$93.2B
Q2 20252,9723.77 billion$91.4B
Q1 20253,0883.76 billion$97.5B
Q4 20243,1633.76 billion$100.0B
Q3 20243,0743.82 billion$111.0B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Pfizer insider trades

InsiderDateTitleTransactionValue
Bourla AlbertAug 12, 2026Chief Executive OfficerPurchase at price 26.34 per share.$1.0M
Damico Jennifer B.Aug 5, 2026OfficerSale at price 25.40 per share.$83,261
Buckley Mortimer J.Aug 5, 2026DirectorPurchase at price 25.52 per share.$960,369
Blaylock Ronald EAug 5, 2026DirectorPurchase at price 25.46 per share.$998,821
Damico Jennifer B.Jun 9, 2026OfficerSale at price 25.70 per share.$51,400
Damico Jennifer B.Mar 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Sahni PayalFeb 25, 2026OfficerConversion of Exercise of derivative security at price 33.82 per share.$1.9M
Mcdermott MichaelFeb 25, 2026OfficerConversion of Exercise of derivative security at price 33.82 per share.$1.3M
Damico Jennifer B.Feb 25, 2026OfficerConversion of Exercise of derivative security at price 33.82 per share.$593,812
Bourla AlbertFeb 25, 2026Chief Executive OfficerConversion of Exercise of derivative security at price 33.82 per share.$16.6M
Lankler Douglas MFeb 25, 2026OfficerConversion of Exercise of derivative security at price 33.82 per share.$4.2M
Fonseca Lidia Ph.D.Feb 25, 2026OfficerConversion of Exercise of derivative security at price 33.82 per share.$1.9M

Newest 12 of 33 insider transactions in the last two years.

Questions and answers

Who owns the most Pfizer stock?

BlackRock Advisors LLC, with 6.74% of the company (as of September 25, 2026). Next: Vanguard Capital Management LLC (6.53%) and State Street Corporation (5.39%).

How many institutions own Pfizer stock?

2,975 institutional holdings reports listed Pfizer shares in Q2 2026, 4.05 billion shares in all worth $102.00 billion.

Are Pfizer insiders buying or selling the stock?

In the last two years insiders reported 3 sales and 5 purchases (33 transactions in all); the newest on file is from August 12, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube